Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those,
Psychedelics company Cybin Inc. CYBN announced an overnight marketed public offering of its units and confirmed its set pricing on an aggregate 24,264,706 Cybin units, at $0.34 each,
Researchers at the University of Eastern Finland have identified plasma protein-based biomarkers capable of identifying adolescents at risk of developing mental health issues.
Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence
Bimervax, the COVID-19 vaccine developed by HIPRA Human Health, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).
More than 4 out of 5 older women survivors of colorectal cancer may be experiencing a range of gastrointestinal symptoms many years after being diagnosed
TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company“), a clinical-stage biopharmaceutical company committed to developing
Estimates suggest that 30%-40% of male carriers, and 8%-16% of premutation carriers will develop FXTAS symptoms. Image credit: Shutterstock/Billion Photos. The US Department of Defense
Source: GlobalData, Deals Database (Accessed: 26 July 2023) © GlobalData. Note: Percentages were calculated from the total number of deals that occurred in 2018–2022. The